Why Fire & Flower (TSX:FAF) Stock Jumped 12% on Monday

Fire & Flower (TSX:FAF) stock hit 52-week highs after a share consolidation and more good news coming the company’s way for investors.

| More on:

Cannabis stocks continue to hit 52-week lows practically across the board. Fire & Flower Holdings (TSX:FAF) managed to recover some of its losses on Monday, jumping 12% in morning trading.

What happened?

Fire & Flower stock rose about 12% on Monday, back to share prices seen last Wednesday in the beginning of the December. This comes after the cannabis stock announced milestones that included adding its PotGuide and Wikileaf to online cannabis retailers on top of consolidating shares.

Its products can now be purchased and fulfilled throughout Ontario, Manitoba, British Columbia, Saskatchewan, and, soon, Alberta. This comes on top of several new announcements made in the last month. These have sent the cannabis stock on a major growth path towards becoming the discount cannabis retailer.

So what?

In the last month alone, Fire & Flower stock announced several new items for its growth strategy. This includes a potential listing on the Nasdaq, which led to the consolidation of shares on Dec. 1. This is a major move towards listing on the United States index, as the company continues to expand in the United States.

These moves are the latest in the company’s growth strategy, where it also announced a partnership with Alimentation Couche-Tard in October. Fire & Flower stock will partner with the parent company of Circle K stores to open new retail locations next door. Alimentation has locations across North America, including the U.S., so major expansion is already in the works.

Now what?

Fire & Flower stock remains one of the strongest cannabis stocks in the industry at a time when many stocks are collapsing all around it. Shares are now at 52-week highs after the price consolidation.

Analysts continue to see it as a great deal in the cannabis industry if you’re willing to be patient and wait for U.S. legalization. But even still, the $202 million cannabis retailer has several growth initiatives underway for solid revenue. Creating store locations next to every Circle K, a Nasdaq listing, and more products online create more earnings opportunities. And that’s more than many other cannabis stocks can claim.

Shares of currently trade at 52-week highs at $5.64 per share as of writing.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends ALIMENTATION COUCHE-TARD INC.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »